Speciality Medi. — 360° view

Speciality Medi, a company in the Pharmaceuticals industry, reported revenue of ₹87 crore and net profit of ₹9.00 crore for the September 2026 quarter.

Speciality Medi. (BSE: SPML) closed at ₹160.00 on 20 Nov 2026. Its market capitalisation is ₹141 crore and it trades at 8.2 times earnings.

Share price
₹160.00 (20 Nov 2026)
Market cap
₹141 Cr (20 Nov 2026)
P/E
8.24 (20 Nov 2026)
Revenue
₹87 Cr (September 2026 quarter)
Net profit
₹9 Cr (September 2026 quarter)
ROCE
25.2% (FY26)
ROE
25.6% (FY26)
Book value
₹91.2 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹381.20 / ₹121.10 (20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
BSE: SPML

Incorporated in 2021, Speciality Medicines Ltd is focused on the export, trading, and distribution of pharmaceutical medicines and vaccines.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.